BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 14687996)

  • 1. Quantification of risk factors for venous thromboembolism: a preliminary study for the development of a risk assessment tool.
    Samama MM; Dahl OE; Quinlan DJ; Mismetti P; Rosencher N
    Haematologica; 2003 Dec; 88(12):1410-21. PubMed ID: 14687996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients.
    Cohen AT; Alikhan R; Arcelus JI; Bergmann JF; Haas S; Merli GJ; Spyropoulos AC; Tapson VF; Turpie AG
    Thromb Haemost; 2005 Oct; 94(4):750-9. PubMed ID: 16270626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada.
    Kahn SR; Panju A; Geerts W; Pineo GF; Desjardins L; Turpie AG; Glezer S; Thabane L; Sebaldt RJ;
    Thromb Res; 2007; 119(2):145-55. PubMed ID: 16516275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study.
    Alikhan R; Cohen AT; Combe S; Samama MM; Desjardins L; Eldor A; Janbon C; Leizorovicz A; Olsson CG; Turpie AG;
    Arch Intern Med; 2004 May; 164(9):963-8. PubMed ID: 15136304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of managed care claims data in the risk assessment of venous thromboembolism in outpatients.
    Russell MW; Taylor DC; Cummins G; Huse DM
    Am J Manag Care; 2002 Jan; 8(1 Suppl):S3-9. PubMed ID: 11822347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An electronic tool for venous thromboembolism prevention in medical and surgical patients.
    Samama MM; Dahl OE; Mismetti P; Quinlan DJ; Rosencher N; Cornelis M; de Vries H; van Beusekom I; Kahan JP
    Haematologica; 2006 Jan; 91(1):64-70. PubMed ID: 16434372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors in venous thromboembolism.
    Martinelli I
    Thromb Haemost; 2001 Jul; 86(1):395-403. PubMed ID: 11487029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous thromboembolic prophylaxis in hospitalized medical patients.
    Stark JE; Kilzer WJ
    Ann Pharmacother; 2004 Jan; 38(1):36-40. PubMed ID: 14742790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective evaluation of patients hospitalized with venous thromboembolism: comparison between cancer and non-cancer patients.
    Kolomansky A; Hoffman R; Sarig G; Brenner B; Haim N
    Isr Med Assoc J; 2006 Dec; 8(12):848-52. PubMed ID: 17214102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applying risk assessment models in non-surgical patients: overview of our clinical experience.
    Davidson BL
    Blood Coagul Fibrinolysis; 1999 Aug; 10 Suppl 2():S85-9. PubMed ID: 10493235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for venous thromboembolism in children.
    Gerotziafas GT
    Int Angiol; 2004 Sep; 23(3):195-205. PubMed ID: 15765033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for venous thromboembolism in the elderly: results of the master registry.
    Ageno W; Agnelli G; Imberti D; Moia M; Palareti G; Pistelli R; Rossi R; Verso M;
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):663-7. PubMed ID: 18832907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment.
    Santamaria MG; Agnelli G; Taliani MR; Prandoni P; Moia M; Bazzan M; Guazzaloca G; Ageno W; Bertoldi A; Silingardi M; Tomasi C; Ambrosio GB;
    Thromb Res; 2005; 116(4):301-6. PubMed ID: 16038714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and risk factors of venous thromboembolism.
    Ageno W; Squizzato A; Garcia D; Imberti D
    Semin Thromb Hemost; 2006 Oct; 32(7):651-8. PubMed ID: 17024592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of deep venous thrombosis in medical patients].
    Bergmann JF; Mahe I
    Ann Med Interne (Paris); 2000 May; 151(3):207-14. PubMed ID: 10896973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous thromboembolism prophylaxis in medically ill patients and the development of strategies to improve prophylaxis rates.
    Stinnett JM; Pendleton R; Skordos L; Wheeler M; Rodgers GM
    Am J Hematol; 2005 Mar; 78(3):167-72. PubMed ID: 15726600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolism in medical patients--the scope of the problem.
    Haas S
    Semin Thromb Hemost; 2003 Dec; 29 Suppl 1():17-21. PubMed ID: 14730474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thrombophilic disorders in venous thromboembolism. The clinical perspective].
    Schmidt B; Schellong S
    Med Klin (Munich); 2003 Mar; 98(3):133-9. PubMed ID: 12647087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of screening on thrombophilia for patients with venous thrombosis.
    Paschôa AF; Guillaumon AT
    Int Angiol; 2006 Mar; 25(1):52-9. PubMed ID: 16520725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of venous thromboembolism.
    Kearon C
    Semin Vasc Med; 2001; 1(1):7-26. PubMed ID: 15199510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.